Roger Li, Urologic oncologist at Moffitt Cancer Center, shared on X:
“Dickon Hayne presenting the results from BCG+MMC trial in the BCG-naive setting
- Possible signal in higher staged patients
- High compliance
- Saves BCG in the era of shortage
Difference between monthly maintenance vs swog
Effect additive vs synergistic.”
More posts featuring ANZUP25.
